Fundamental Valuation Report Daxor(DXR:ASE) Healthcare:Medical Instruments & Supplies This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$10.03 (USD) 04/23/2021 Weighted Valuation$8.50 (USD) Overall RatingOvervalued by 15.3% Valuation Models Multiples: $8.50 (USD) …
Daxor (DXR:ASE) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Ekso Bionics Holdings(EKSO:NAS) Healthcare:Medical Instruments & Supplies This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$5.70 (USD) 04/23/2021 Weighted Valuation$5.37 (USD) Overall RatingOvervalued by 5.8% Valuation Models …
Ekso Bionics Holdings (EKSO:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report EMCOR Gr(EME:NYS) Industrials:Engineering & Construction This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$120.96 (USD) 04/23/2021 Weighted Valuation$108.75 (USD) Overall RatingOvervalued by 10.1% Valuation Models Comparables: $144.02 (USD) …
EMCOR Gr (EME:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report EPAM Systems(EPAM:NYS) Technology:Information Technology Services This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$458.15 (USD) 04/23/2021 Weighted Valuation$425.00 (USD) Overall RatingOvervalued by 7.2% Valuation Models Comparables: $292.13 (USD) …
EPAM Systems (EPAM:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report EPR Props(EPR:NYS) Real Estate:REIT – Retail This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$47.68 (USD) 04/23/2021 Weighted Valuation$43.94 (USD) Overall RatingOvervalued by 7.8% Valuation Models Multiples: $40.90 …
EPR Props (EPR:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Columbia Sportswear(COLM:NAS) Consumer Cyclical:Apparel Manufacturing This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$111.89 (USD) 04/22/2021 Weighted Valuation$106.00 (USD) Overall RatingOvervalued by 5.3% Valuation Models Adjusted Book …
Columbia Sportswear (COLM:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Chevron(CVX:NYS) Energy:Oil & Gas Integrated This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$100.95 (USD) 04/22/2021 Weighted Valuation$93.60 (USD) Overall RatingOvervalued by 7.3% Valuation Models Adjusted Book …
Chevron (CVX:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Chimerix(CMRX:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$8.25 (USD) 04/21/2021 Weighted Valuation$6.79 (USD) Overall RatingOvervalued by 17.8% Valuation Models Comparables: $6.79 (USD) Valuation Methods This …
Chimerix (CMRX:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Cross Country Healthcare(CCRN:NAS) Industrials:Staffing & Employment Services This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$12.67 (USD) 04/20/2021 Weighted Valuation$11.51 (USD) Overall RatingOvervalued by 9.1% Valuation Models …
Cross Country Healthcare (CCRN:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Cidara Therapeutics(CDTX:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$2.03 (USD) 04/20/2021 Weighted Valuation$1.92 (USD) Overall RatingOvervalued by 5.4% Valuation Models Comparables: $1.67 (USD) (in order …
Cidara Therapeutics (CDTX:NAS) Fundamental Valuation Report Read more »
Read More